MA26450A1 - Dimesylate de cis-1-(3-ethoxyphenyl)-1-(4-phenyl-piperazine-1-yl)-4-methylcyclohexane, procede pour sa preparation et composition pharmaceutique. - Google Patents

Dimesylate de cis-1-(3-ethoxyphenyl)-1-(4-phenyl-piperazine-1-yl)-4-methylcyclohexane, procede pour sa preparation et composition pharmaceutique.

Info

Publication number
MA26450A1
MA26450A1 MA24872A MA24872A MA26450A1 MA 26450 A1 MA26450 A1 MA 26450A1 MA 24872 A MA24872 A MA 24872A MA 24872 A MA24872 A MA 24872A MA 26450 A1 MA26450 A1 MA 26450A1
Authority
MA
Morocco
Prior art keywords
dimesylate
ethoxyphenyl
methylcyclohexane
piperazine
cis
Prior art date
Application number
MA24872A
Other languages
English (en)
French (fr)
Inventor
R Brostrom Lyle
A Whipple Laurie
J M Allen Douglas
S Kord Alireza
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26450A1 publication Critical patent/MA26450A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA24872A 1996-11-26 1997-11-25 Dimesylate de cis-1-(3-ethoxyphenyl)-1-(4-phenyl-piperazine-1-yl)-4-methylcyclohexane, procede pour sa preparation et composition pharmaceutique. MA26450A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
MA26450A1 true MA26450A1 (fr) 2004-12-20

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24872A MA26450A1 (fr) 1996-11-26 1997-11-25 Dimesylate de cis-1-(3-ethoxyphenyl)-1-(4-phenyl-piperazine-1-yl)-4-methylcyclohexane, procede pour sa preparation et composition pharmaceutique.

Country Status (23)

Country Link
US (1) US5914329A (cg-RX-API-DMAC7.html)
EP (1) EP0944611B1 (cg-RX-API-DMAC7.html)
JP (1) JP3120861B2 (cg-RX-API-DMAC7.html)
AP (1) AP9701148A0 (cg-RX-API-DMAC7.html)
AR (1) AR010304A1 (cg-RX-API-DMAC7.html)
AT (1) ATE257472T1 (cg-RX-API-DMAC7.html)
AU (1) AU4792497A (cg-RX-API-DMAC7.html)
BR (1) BR9713538A (cg-RX-API-DMAC7.html)
CA (1) CA2272927C (cg-RX-API-DMAC7.html)
DE (1) DE69727155T2 (cg-RX-API-DMAC7.html)
DK (1) DK0944611T3 (cg-RX-API-DMAC7.html)
ES (1) ES2213207T3 (cg-RX-API-DMAC7.html)
GT (1) GT199700123A (cg-RX-API-DMAC7.html)
HN (1) HN1997000154A (cg-RX-API-DMAC7.html)
HR (1) HRP970640A2 (cg-RX-API-DMAC7.html)
ID (1) ID18964A (cg-RX-API-DMAC7.html)
MA (1) MA26450A1 (cg-RX-API-DMAC7.html)
PA (1) PA8441701A1 (cg-RX-API-DMAC7.html)
PE (1) PE17099A1 (cg-RX-API-DMAC7.html)
PT (1) PT944611E (cg-RX-API-DMAC7.html)
TN (1) TNSN97191A1 (cg-RX-API-DMAC7.html)
WO (1) WO1998023603A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA9710587B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
EP2002827A2 (en) 2001-12-05 2008-12-17 The Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
WO2003057886A2 (en) 2002-01-09 2003-07-17 Arexis Ab Detection of mutations
KR100716389B1 (ko) * 2004-11-23 2007-05-11 동화약품공업주식회사 Ｎ-히드록시－４－｛５－［４－（5－이소프로필－２－메틸－１,３－티아졸－4－일）페녹시］펜톡시｝벤즈아미딘 ２메탄술폰산염
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
DE69727155D1 (de) 2004-02-12
DK0944611T3 (da) 2004-04-13
US5914329A (en) 1999-06-22
DE69727155T2 (de) 2004-07-08
HRP970640A2 (en) 1998-10-31
AP9701148A0 (en) 1998-01-31
EP0944611A1 (en) 1999-09-29
CA2272927A1 (en) 1998-06-04
JP3120861B2 (ja) 2000-12-25
ID18964A (id) 1998-05-28
WO1998023603A1 (en) 1998-06-04
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
GT199700123A (es) 1999-05-19
ZA9710587B (en) 1999-05-25
ES2213207T3 (es) 2004-08-16
PT944611E (pt) 2004-04-30
HN1997000154A (es) 1999-02-09
TNSN97191A1 (fr) 2005-03-15
AR010304A1 (es) 2000-06-07
JP2000505110A (ja) 2000-04-25
BR9713538A (cg-RX-API-DMAC7.html) 2000-03-21
EP0944611B1 (en) 2004-01-07
PA8441701A1 (es) 2000-05-24
ATE257472T1 (de) 2004-01-15
AU4792497A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23942A1 (fr) Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
FR2748026B1 (fr) Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2752091B1 (fr) Composition pour electrode positive, procede de preparation
DK0719788T3 (da) Fremgangsmåde til fremstilling af 1-(2'-deoxy-2',2'-difluor-D-ribofuranosyl)-4-aminopyrimidin-2-on-hydrochlorid
MA24747A1 (fr) Composition de mesylate de trovafloxacine et procede pour sa preparation
EP0745315A4 (en) SOLDERING PROCESS
MA26417A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant
MA26523A1 (fr) Modification thermodynamiquement stable de 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy) ethylamino)-2-propanole, procede pour sa preparation et compositions pharmaceutiques le comprenant
FR2780622B1 (fr) Applicateur pour produit delitescent, ensemble comportant un tel applicateur et procede
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
FR2741625B1 (fr) Agent polymerique de filtrage des ultraviolets et procede pour sa preparation
MA24010A1 (fr) Catalyseurs pour l'oxychloration de l'ethylene, procede pour les preparer et procede d'oxychloration utilisant ceux-ci
DZ3041A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procédé pour sa préparation.
FR2770534B1 (fr) Procede pour enlever des graffitis
MA26582A1 (fr) Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant
CU22890A3 (es) Nuevo proceso de preparacion de derivados de fenilimidazolidina.
FR2749779B1 (fr) Procede de presulfuration de catalyseurs d'hydrotraitement
FR2691078B1 (fr) Catalyseur d'hydrodesulfuration, procedes pour sa preparation et procede d'hydrodesulfuration l'utilisant.
EP1052015A4 (en) CATALYST FOR HYDROTREATING HEAVY OIL, CARRIER FOR THE CATALYST, METHOD FOR PRODUCING THE CATALYST
FR2700956B1 (fr) Composition cosmetique et pharmaceutique et procede pour sa preparation.
BR9806811B1 (pt) método e aparelho para utilização no aperfeiçoamento da qualidade de tráfego de voz num sistema de telefonia.